Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 25% ± 8% | |
peripheral blood | 14 studies | 29% ± 10% | |
brain | 10 studies | 30% ± 15% | |
eye | 9 studies | 29% ± 13% | |
intestine | 6 studies | 23% ± 8% | |
kidney | 4 studies | 23% ± 1% | |
bone marrow | 4 studies | 21% ± 3% | |
liver | 4 studies | 31% ± 10% | |
pancreas | 3 studies | 36% ± 12% | |
uterus | 3 studies | 33% ± 13% | |
adipose | 3 studies | 25% ± 3% | |
lymph node | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5498.81 | 21 / 21 | 100% | 35.06 | 504 / 504 |
breast | 100% | 6593.44 | 459 / 459 | 100% | 49.52 | 1118 / 1118 |
esophagus | 100% | 5412.41 | 1445 / 1445 | 100% | 35.38 | 183 / 183 |
intestine | 100% | 5660.49 | 966 / 966 | 100% | 32.28 | 527 / 527 |
lung | 100% | 5740.12 | 578 / 578 | 100% | 35.61 | 1155 / 1155 |
ovary | 100% | 9135.37 | 180 / 180 | 100% | 28.92 | 430 / 430 |
prostate | 100% | 5805.65 | 245 / 245 | 100% | 42.32 | 502 / 502 |
stomach | 100% | 4116.45 | 359 / 359 | 100% | 30.12 | 286 / 286 |
brain | 100% | 4877.47 | 2640 / 2642 | 100% | 45.50 | 705 / 705 |
uterus | 100% | 7461.29 | 170 / 170 | 100% | 43.63 | 458 / 459 |
kidney | 100% | 4273.74 | 89 / 89 | 100% | 37.01 | 899 / 901 |
thymus | 100% | 6485.99 | 653 / 653 | 100% | 46.52 | 603 / 605 |
pancreas | 100% | 3525.82 | 328 / 328 | 99% | 35.72 | 177 / 178 |
adrenal gland | 100% | 3738.58 | 258 / 258 | 99% | 28.47 | 227 / 230 |
skin | 100% | 6578.34 | 1809 / 1809 | 99% | 33.06 | 465 / 472 |
liver | 100% | 2486.46 | 226 / 226 | 97% | 17.82 | 392 / 406 |
adipose | 100% | 5962.72 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5500.16 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.52 | 29 / 29 |
muscle | 100% | 4038.84 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6133.28 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 40.52 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.04 | 1 / 1 |
heart | 99% | 3137.59 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 3748.98 | 895 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 24.02 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009048 | Biological process | dosage compensation by inactivation of X chromosome |
GO_0006376 | Biological process | mRNA splice site recognition |
GO_0007283 | Biological process | spermatogenesis |
GO_0001701 | Biological process | in utero embryonic development |
GO_0010608 | Biological process | post-transcriptional regulation of gene expression |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0048160 | Biological process | primary follicle stage |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0006406 | Biological process | mRNA export from nucleus |
GO_0110104 | Biological process | mRNA alternative polyadenylation |
GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003729 | Molecular function | mRNA binding |
GO_1990247 | Molecular function | N6-methyladenosine-containing RNA reader activity |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | YTHDC1 |
Protein name | Alternative protein YTHDC1 YTH domain-containing family protein YTH domain containing 1 (YTH domain-containing protein 1) YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B) |
Synonyms | YT521 KIAA1966 |
Description | FUNCTION: Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs . M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability . Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 . Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing . In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping: this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing . May also regulate alternative splice site selection . Also involved in nuclear export of m6A-containing mRNAs via interaction with SRSF3: interaction with SRSF3 facilitates m6A-containing mRNA-binding to both SRSF3 and NXF1, promoting mRNA nuclear export . Involved in S-adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts, probably by binding m6A-containing MAT2A mRNAs (By similarity). Also recognizes and binds m6A on other RNA molecules . Involved in random X inactivation mediated by Xist RNA: recognizes and binds m6A-containing Xist and promotes transcription repression activity of Xist . Also recognizes and binds m6A-containing single-stranded DNA . Involved in germline development: required for spermatogonial development in males and oocyte growth and maturation in females, probably via its role in alternative splicing (By similarity). . FUNCTION: Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, and regulates mRNA stability. M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing. . |
Accessions | ENST00000615500.4 [Q96MU7-1] ENST00000627168.2 J3QR07 ENST00000505251.1 L0R8L2 ENST00000625493.1 J3KS01 ENST00000355665.7 [Q96MU7-2] ENST00000579690.5 ENST00000628264.1 Q96MU7 ENST00000510746.1 J3KRG5 ENST00000629100.1 ENST00000344157.9 [Q96MU7-1] ENST00000507529.1 ENST00000613637.3 [Q96MU7-2] J3KRW0 |